## min read

What is Attention-Seeking Behavior?

|

October 22, 2026

Summarize with AI

What is Attention-Seeking Behavior?

Someone calls a friend "such an attention seeker," and everyone nods. Maybe it's a coworker who turns every meeting into a story about themselves, a partner who escalates every disagreement, or a teenager whose posts get more dramatic by the week. Or maybe you've wondered whether the label fits you.

Attention-seeking behavior is any behavior aimed, consciously or not, at getting other people to notice, respond, or reassure. Everyone does it sometimes. Wanting to be seen is a basic human need. It becomes a problem when it's persistent, when it disrupts relationships or work, or when it's the visible edge of something harder underneath: loneliness, a mood episode, a personality disorder, or a crisis.

What counts as attention-seeking behavior?

Common examples include:

  • Exaggerating stories or symptoms to get a reaction
  • Steering conversations back to yourself
  • Dramatic emotional displays out of proportion to the situation
  • Fishing for compliments or reassurance
  • Provocative statements, posts, or clothing meant to stand out
  • Starting conflict to get engagement, even negative engagement

None of these, on its own, says anything about mental health. Context matters more than any single behavior: how often it happens, how much it costs the person, and what's driving it.

Why do people seek attention?

There's rarely a single reason. Common drivers include:

  • Loneliness and unmet needs for connection. When people feel unseen, any response can feel better than none.
  • Low self-worth. External validation can stand in for an internal sense of being okay.
  • Learned patterns. In some families, the only reliable way to get a response was to escalate. Habits learned early can carry into adulthood.
  • Stress or crisis. Even people who rarely seek attention may reach for it during a breakup, a loss, or a period of instability.
  • Social media. Likes and comments offer fast, measurable attention, which makes it easy to chase.

Sometimes, though, behavior that looks like attention-seeking is a symptom of a mental health condition, and treating it as a character flaw misses the point.

Is attention-seeking behavior a sign of a disorder?

Usually not. But persistent, intense attention-seeking can be part of several conditions.

"Attention-seeking disorder" isn't a real diagnosis

People often search for "attention seeking disorder." There's no condition by that name in the DSM-5. The diagnosis most closely tied to attention-seeking is histrionic personality disorder, and attention-seeking can also show up in borderline personality disorder, narcissistic personality disorder, and during manic episodes of bipolar disorder.

Histrionic personality disorder

Histrionic personality disorder (HPD) is defined by a long-standing pattern of excessive emotionality and attention-seeking. According to the MSD Manual, it affects about 2% of people in the U.S. Under DSM-5-TR criteria, a diagnosis requires at least five of the following, beginning by early adulthood:

  • Discomfort when not the center of attention
  • Inappropriately seductive or provocative interactions
  • Rapidly shifting, shallow-seeming emotions
  • Consistent use of physical appearance to draw attention
  • Speech that is vague and lacking in detail
  • Dramatic, theatrical, exaggerated emotional expression
  • Being easily influenced by others or situations
  • Seeing relationships as more intimate than they are

A StatPearls review on NCBI describes HPD as an enduring condition that typically begins in late adolescence or early adulthood. The key difference from ordinary attention-seeking is that the pattern is pervasive: it shows up across relationships and settings, for years, and causes real distress or impairment.

Borderline personality disorder

In borderline personality disorder (BPD), intense fear of abandonment, unstable relationships, and rapidly shifting moods can lead to behavior that others read as attention-seeking. Usually it's something closer to panic: an attempt to keep someone from leaving. BPD can also look the opposite way, turned inward. We've written about that in quiet BPD and about the outward-facing petulant type of BPD.

Bipolar disorder

During a manic episode, the NIMH describes symptoms such as feeling very up or elated, talking fast about many things, feeling unusually important, talented, or powerful, and an excessive appetite for pleasurable activities. To others, that can look like a bid for attention. It's actually a mood episode, and it needs treatment.

When "attention-seeking" is really a cry for help

Talk of suicide, self-harm, or hopelessness is sometimes dismissed as "just attention-seeking." That's dangerous. The NIMH's warning signs of suicide include talking about wanting to die, feeling like a burden, feeling hopeless or trapped, and withdrawing from friends. These are reasons to respond, not to roll your eyes.

Even if someone has said similar things before, take it seriously. Ask directly. Stay with them. If you or someone you know is in danger, call or text 988, the Suicide & Crisis Lifeline, or call 911.

How attention-seeking affects relationships

Persistent attention-seeking tends to wear people down. Friends and partners can feel exhausted, manipulated, or stuck in cycles of crisis and reconciliation. Over time, people pull back, which deepens the loneliness that often drove the behavior in the first place.

That cycle is why labeling someone an "attention seeker" rarely helps. It names the behavior without touching the need underneath.

What helps

When attention-seeking is a habit rather than a symptom, change usually starts with noticing the need before acting on it. Is it reassurance, connection, recognition? Saying that need directly often gets a better response than dramatizing it.

When it's part of a mental health condition, treatment targets the condition:

  • Personality disorders. Psychotherapy is the main treatment. The MSD Manual notes that for HPD, psychotherapy focusing on underlying conflicts may help. For BPD, a 2020 Cochrane review found that psychotherapy reduced symptom severity, with dialectical behavior therapy and mentalization-based treatment the most studied.
  • Bipolar disorder. According to the NIMH, bipolar disorder usually requires lifelong treatment, typically medication combined with psychotherapy.

If you're on the other side of it, as a partner, parent, or friend, it helps to respond to the underlying need calmly and consistently, while setting clear limits on behavior you can't sustain. For more, see how to help someone with mental health issues.

When to look for more support

Consider a professional evaluation when attention-seeking is constant, damages relationships or work, comes with intense mood swings or fear of abandonment, or comes with any talk of self-harm.

At Amae Health, our clinics specialize in conditions including Borderline Personality Disorder and bipolar disorder. Our care teams bring psychiatrists, therapists, peer mentors, and care coordinators under one roof, working from one treatment plan, so the pattern behind the behavior gets looked at, not just the behavior itself.

Frequently asked questions

What is an attention seeker?

"Attention seeker" is an informal label for someone who often behaves in ways meant to draw notice or reactions from others. It isn't a diagnosis, and it often oversimplifies what's going on.

Is attention-seeking a mental illness?

No. Attention-seeking is a behavior, not a diagnosis. Persistent, pervasive attention-seeking can be part of histrionic personality disorder, and it can also appear in borderline personality disorder and during manic episodes of bipolar disorder.

What causes attention-seeking behavior in adults?

Common drivers include loneliness, low self-worth, patterns learned in childhood, stress or crisis, and the pull of social media. In some cases, it's a symptom of a mental health condition.

How do you respond to someone who is attention-seeking?

Respond to the need behind the behavior, such as reassurance or connection, without rewarding escalation. Set calm, consistent limits. And never dismiss talk of suicide or self-harm as attention-seeking.

Key takeaways

  • Attention-seeking behavior is common and human. It becomes a concern when it's persistent and harmful.
  • "Attention-seeking disorder" isn't a diagnosis. Histrionic personality disorder is the condition most closely tied to it, and it can also appear in BPD and bipolar disorder.
  • Talk of suicide or self-harm should always be taken seriously, never written off as attention-seeking.
  • The most useful response is to address the need underneath the behavior.

If attention-seeking is part of a bigger pattern of mood swings, unstable relationships, or self-harm, for you or someone you love, request an intake appointment. Our team will explain how an evaluation works and what to expect from the first visit.

Reccomended for you

# min read

Schizophrenia Treatment Options: Navigating the Path to Recovery

By

Sonia Garcia

|

May 15, 2026

A schizophrenia diagnosis arrives to a person in a small room, and rearranges things without asking — the way a conversation feels, the way a plan for next year suddenly needs rewriting, the way someone you love looks at you and you can't quite tell what they're thinking anymore. Most of what you'll read about schizophrenia treatment options is either clinical to the point of cold, or optimistic in a way that skips the hard parts. 

Schizophrenia is a chronic condition. In 2026, it is also named one of the most treatable severe mental illnesses in psychiatry. The medications have quietly changed over the last two years, with the care models changing even faster. And the question clinicians now ask (is this person living a life they recognize as their own?) is a better question than the one psychiatry asked a generation ago.

This is a guide to what schizophrenia treatment actually looks like now.

What "Treatment" Means for Schizophrenia in 2026

For most of psychiatry's history, treating schizophrenia meant turning down the volume on hallucinations and delusions and hoping everything else would hold. Consequently, it often didn't. The older medications were blunt instruments — they could quiet the psychosis while leaving a person sedated, emotionally flat, and unable to concentrate. A patient could be symptom-free on paper and still lose their apartment, their job, and their social world, not because the illness had won, but because the treatment had taken too much with it.

That old goal has been replaced.

The modern target is functional recovery: the ability to live a connected, productive life, be it work or school. Rebuilding the relationships that came apart during the acute phase. Living on your own terms. Functional recovery is not the same as symptom elimination. Some of the people who reach it still hear voices, and some of the people with zero symptoms can't hold a routine. What functional recovery actually requires, almost without exception, is a care plan that treats medication, therapy, physical health, and social support as one whole problem instead of four.

Pharmacological Breakthroughs: A New Era of Medication

Medication is the floor of schizophrenia treatment, not the ceiling. For about 40 years, that floor was built of one material: antipsychotics that bind dopamine D2 receptors and block the signal. That is still the starting point for most patients in 2026. What has quietly changed is the field, which now has options that were not there two years ago.

Second-Generation Antipsychotics: The Current Standard

Risperidone, olanzapine, aripiprazole, paliperidone, quetiapine. Those are the names that will likely appear first in any conversation with a psychiatrist. They're called "second-generation" or "atypical" antipsychotics because together, they work on dopamine and serotonin, producing a more favorable profile for negative symptoms and cognitive effects than the drugs that came before them.

They work. They also come at a cost.

The trade-off is metabolic. Weight gain. Elevated blood sugar. Shifts in lipid panels that, untracked, add up to real cardiovascular risk over time. A care team that prescribes these medications without monitoring the body is doing half the job. Metabolic monitoring is not optional.

The Non-Dopaminergic Revolution: Cobenfy and Muscarinic Agonists

In September 2024, something happened in schizophrenia pharmacology for the first time in about 35 years. The FDA approved xanomeline-trospium (Cobenfy, formerly known as KarXT), and the mechanism was not a variation on the dopamine theme. Cobenfy works on muscarinic receptors (specifically the M1 and M4 subtypes), meaning the biological pathway it acts on is different in kind, not just in detail (Yale Medicine).

Here is why that matters.

Roughly one-third of patients don't respond adequately to dopamine-based medications. The metabolic and movement-related side effects of the older drugs are also downstream of dopamine blockade. Cobenfy doesn't block dopamine, which is why early trials suggest it may avoid some of that side effect profile.

Long-term data is still accumulating. For now, the field has its first new mechanism in a generation.

Long-Acting Injectables: Reducing the Daily Burden

Long-acting injectable antipsychotics, or LAIs, deliver a single dose that lasts weeks or even months. For patients whose relapses have traced back to missed pills, that is a meaningful shift.

The evidence has caught up with the intuition. A 2022 network meta-analysis in World Psychiatry pooled 92 randomized trials and 22,645 participants and found that LAIs hold up against daily oral antipsychotics in preventing relapse (Ostuzzi et al., 2022). Real-world studies of US Medicare patients have shown LAIs are associated with lower rates of psychiatric hospitalization and treatment discontinuation.

LAIs are not right for every patient. Some people find meaning in the daily ritual of a pill. Some have had painful experiences with injections. The right answer comes out of a real conversation with a psychiatrist who has the patient's history in front of them.

Models of Care: Why the Environment Matters

The same medication can produce very different outcomes depending on how it is delivered. Two patients on the same dose of the same drug can end up in very different places a year later. The difference is usually the system around them.

Coordinated Specialty Care (CSC)

In 2026, coordinated Specialty Care is the standard for early psychosis.It is also one of the clearest examples in psychiatry of a care model producing better outcomes than a new drug would. The American Psychiatric Association formally endorsed it in its 2020 practice guideline (APA Practice Guideline for the Treatment of Patients With Schizophrenia), and it came out of the NIMH RAISE research initiative.

The model is a single team of clinicians working from one plan: medication management, individual therapy, supported employment and education, family education, and case management that actually happens, rather than getting sent to five different offices on five different days.

The data is strong. In the NIMH RAISE Early Treatment Program, patients who received CSC had hospitalization rates of 23% compared with 44% in usual community care (NIMH: Team-based Treatment is Better for First Episode Psychosis). They were also more likely to stay in school or employment and experienced greater improvement in symptoms, interpersonal relationships, and quality of life (Kane et al., American Journal of Psychiatry, 2016).

That is a halving of hospitalization risk, produced by a care model rather than a new molecule.

CSC was built for early psychosis. For patients further along in treatment, other models fit better.

Integrated Outpatient Care for Severe Mental Illness

For patients past the first-episode window, integrated outpatient care takes the same principle as CSC and adapts it for the long haul. The model brings psychiatrists, therapists, primary care physicians, dietitians, health coaches, peer mentors, and clinical care coordinators under one roof, working from a single shared plan.

The problem it solves is fragmentation. In the usual picture, a patient has a psychiatrist at one office, a therapist at another, a primary care provider at a third, and if case management exists at all, it runs on lost email attachments. Small things become crises. Crises become hospitalizations. Hospitalizations become the next relapse.

But it doesn't have to work that way.

This is the model our integrated outpatient clinics are built on. We see adults 18 and older. Our care team is designed so that mental health, physical health, and everyday function are handled in the same place, by people who talk to each other. The patient is not the one running the coordination.

Crisis Services and Long-Term Stability

Crisis services are not long-term care, and long-term care is not crisis services. Inpatient hospitalization exists to keep people safe when symptoms are acute. It is essential, and it saves lives. But it is not designed to produce long-term stability, and the handoff from inpatient to outpatient is the highest-risk period for readmission. That handoff is where integrated outpatient care earns its keep.

Evidence-Based Psychosocial Interventions

Medication does one job well. It quiets the biology. Everything else is outside what a pill can do: how a person thinks about what is happening to them, how they rebuild relationships that came apart during the acute phase, how they get back into work or school.

That is where psychosocial interventions come in.

Cognitive Behavioral Therapy for Psychosis (CBTp)

CBT for Psychosis, usually shortened to CBTp, is not standard CBT with a few tweaks. It is a specialized protocol built from the ground up for people who hear voices, hold persistent unusual beliefs, or are trying to function while symptoms are still present. The APA practice guideline gives CBTp a 1B rating, which translates roughly to "the evidence is strong and clinicians should offer this" (APA Practice Guideline, 2020).

What CBTp actually does in a session is teach specific skills. Reality testing. Cognitive distancing from distressing voices. Stress-reduction techniques for the moments when symptoms spike. Coping strategies for persistent delusions that have not responded fully to medication. The goal is not to eliminate the symptoms. It is to change the relationship a person has with them.

Social Skills and Vocational Training

Skills erode during acute episodes. A patient who was holding a job six months ago and had friends two years ago can come back from a hospitalization and find that the conversational rhythm, the workplace reflexes, and the social scaffolding are all gone. Not permanently. Just not where they left them.

Structured social skills training is what it sounds like: deliberate practice. Starting conversations. Reading a room at work. Managing conflict without escalation. Re-entering relationships that went quiet during the acute phase. Supported employment programs pair these skills with real job coaching, and the evidence is that they help people get and keep work when traditional vocational rehabilitation has not.

Cognitive Remediation

Hallucinations and mood can stabilize while the harder, quieter symptoms persist: forgetting appointments, losing the thread of a conversation, struggling to plan a week. These are the symptoms that sit between "stable" and "back to a life I recognize." For many patients, they are what actually prevents the return to work or school.

Cognitive remediation is structured training for those skills. Memory exercises. Attention work. Executive function practice. The programs are not new, but they are one of the most underprescribed interventions in this space. They will not cure cognitive symptoms, but they can meaningfully improve day-to-day function.

The Role of Family and Community Support

No one recovers from schizophrenia alone. That is not a sentimental claim, but a finding that has been reproduced in study after study over several decades.

Family psychoeducation is one of the most consistently supported non-medication interventions in the books. The idea is simple: when the people a patient lives with understand what schizophrenia is, what the medications do, and how to communicate in hard moments, relapse rates drop. A concept in the research called "expressed emotion" describes a household climate marked by high levels of criticism, hostility, or emotional over-involvement. When that climate softens, relapse rates soften with it. Nothing about this says families cause schizophrenia. They don't. But the environment in which treatment either catches or slips is incredibly important.

Community reintegration carries the same weight. A stable apartment. A part-time job, even a small one. Peer support groups. A faith community if that fits. Friendships that survive the acute phase. These are not "lifestyle" factors that sit outside treatment. They are the treatment. A patient with housing and a routine has a very different clinical trajectory from the same patient without them.

How to Choose Among Schizophrenia Treatment Options

The question families ask us is almost never "should we get treatment." It is "how do we pick the right place." A few things matter more than the rest in that decision.

Start with the intake. A good assessment is not a form that takes 20 minutes to fill out. It is a conversation that covers psychiatric history, medication history and response, current symptoms, physical health, substance use, the home situation, and what the patient actually wants out of treatment. If the intake is structured as a checklist, the treatment plan will be too.

Ask how the team communicates. Is there a dedicated case manager? Does the psychiatrist read the therapist's notes? Is metabolic monitoring built into the schedule? Is family involvement standard? Are outcomes tracked? These are the questions we built our care model to answer, and a clinic that stumbles on them is worth a second look.

Insist on shared decision-making. A patient is a participant in their treatment, not a recipient of it. A good clinician lays out the trade-offs of each medication in plain language, listens to what the patient wants, and makes decisions alongside them. A clinician who rushes that or waves it off is telling you something.

Frequently Asked Questions

Q: Can schizophrenia be cured?

Not cured in the traditional sense. Schizophrenia is managed, which is a word that sounds smaller than it is. "Managed" in 2026 can mean living for decades with minimal disruption, working, keeping relationships, and needing medical care the way a person with diabetes does. Functional recovery is achievable for a meaningful number of patients, though not all.

Q: What happens if I stop taking my medication?

The risk of relapse rises sharply. What makes stopping tricky is the delay. Many people who discontinue antipsychotic medication feel fine for weeks, sometimes months, before symptoms return. That gap is long enough to conclude the medication wasn't necessary, and then to be caught off guard when symptoms do come back. Talk to your prescriber before making any changes.

Q: Are there natural treatments for schizophrenia?

Sleep, exercise, nutrition, and stress management support mental health and matter for anyone living with schizophrenia. They are not a substitute for medical treatment. If something is marketed as a "natural cure" for schizophrenia, that is a reason to stop reading. Supplements, herbs, and alternative therapies have not been shown to treat the underlying biology of the condition. Some interact with prescribed medications in ways that can be dangerous.

Q: How do I help a loved one who refuses treatment?

This is the question we hear most from families, and it is the hardest one. A few things help:

  • Anosognosia, a lack of awareness of one's illness, is itself a symptom of schizophrenia. It is not denial. Understanding the difference can change how you approach the conversation.
  • The LEAP method (Listen, Empathize, Agree, Partner), developed by Dr. Xavier Amador, was built for exactly these situations.
  • NAMI's Family-to-Family programs teach communication skills and connect families with others walking the same path.
  • In an acute safety crisis, call 988, the Suicide and Crisis Lifeline, or your local mobile crisis team.

Moving Toward Functional Recovery

A schizophrenia diagnosis is a serious event. It is not a verdict.

The range of schizophrenia treatment options has meaningfully widened since 2024. New medications. New evidence about old medications. Care models with strong outcomes data. Psychosocial interventions that help with the parts of recovery medication cannot touch. The clinical goal has moved from quieting the biology to helping a person live a life they recognize as their own.

What most patients and families need is not a single treatment.

They need a team that treats the whole picture, which means symptoms, physical health, relationships, work, and function, as one problem instead of four.

If you or someone you love is living with schizophrenia, schizoaffective disorder, or a related condition, Amae Health is here to talk. Our care teams include psychiatrists, therapists, primary care providers, dietitians, health coaches, peer mentors, and clinical care coordinators, all working from one shared plan. We see adults 18 and older at our clinics in Los Angeles, Los Altos, San Mateo, Raleigh, New York, and Brooklyn. To start the conversation, request an intake appointment.

‍

Citations

  1. 3 Things to Know About Cobenfy, Yale Medicine. Tier 4 (major academic medical center).
  2. Ostuzzi et al., "Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants," World Psychiatry, 2022. Tier 1 (peer-reviewed).
  3. Kane et al., "Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program," American Journal of Psychiatry, 2016. Tier 1 (peer-reviewed).
  4. NIMH: Team-based Treatment is Better for First Episode Psychosis. Tier 2 (government).

The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, 2020. Tier 3 (professional association).

# min read

What Is Petulant BPD? Signs, Causes, and Treatment

By

Sonia Garcia

|

November 6, 2026

Petulant BPD is an informal name for one of four subtypes of Borderline Personality Disorder described by psychologist Theodore Millon. It isn't a separate diagnosis: petulant borderline personality disorder doesn't appear in the DSM-5-TR, and a clinician would diagnose Borderline Personality Disorder (BPD). People described this way tend to show their distress on the outside, through irritability, resentment, stubbornness, and relationships that swing between clinging and pushing away. And because it's BPD, it's treatable.

Is Petulant BPD a Real Diagnosis?

Not as its own diagnosis. The diagnosis is BPD, which a licensed mental health professional makes after a full evaluation, usually an interview about symptoms, history, and family background.

Subtypes are descriptive. Millon described four BPD subtypes: discouraged, impulsive, petulant, and self-destructive. Each one is a way of grouping the patterns a person with BPD tends to show most. They help a partner or parent see why a loved one's BPD may look nothing like the textbook description.

There are no reliable figures on how many people with BPD fit the petulant pattern. Many people show traits from more than one subtype.

Petulant BPD Symptoms and Signs

Petulant BPD symptoms are the core features of BPD, expressed outwardly. Underneath most of them sits an intense fear of being rejected or left. That doesn't make the behavior easy to live with. It makes it easier to understand.

Irritability and anger that flares quickly

Small things can set off big reactions: a late reply, a change of plans, a tone of voice. The anger often comes fast and fades fast, sometimes followed by guilt or shame. If outbursts are a regular problem, our guide to managing emotional outbursts covers practical steps.

Resentment and feeling unappreciated

Resentment often comes up in descriptions of the petulant pattern: a person may feel chronically overlooked, as if others never give back what they put in. Old grievances resurface in new arguments.

Passive-aggressive behavior and stubbornness

For some people, instead of saying "I'm hurt," the hurt leaks out sideways: sulking, silent treatment, agreeing and then not following through, or digging in on a small point. Stubbornness may work as self-protection, a way to avoid feeling controlled.

Swinging between neediness and pushing people away

This is the push-pull pattern. One day the person wants constant closeness and reassurance. The next, they pick a fight or withdraw, sometimes to test whether the other person stays.

Intense fear of abandonment

Real or imagined signs of rejection can feel unbearable. A partner's night out with friends can register as proof they're leaving.

All-or-nothing thinking (splitting)

People and situations get sorted into all good or all bad, with little room in between. A friend can go from "the only one who understands me" to "just like everyone else" after a single disappointment.

Chronic emptiness

Many people with BPD describe a persistent hollow feeling, a sense of not knowing who they are or what they want.

Mood shifts in BPD often last from a few hours to a few days and tend to follow events, which is one way they differ from the longer mood episodes described in our article on BPD vs. bipolar. Substance use and eating disorders can also occur alongside BPD, and these co-occurring disorders shape how treatment is planned.

BPD and Controlling Behavior

BPD controlling behavior is one of the hardest parts of the petulant pattern for partners and families. It can look like:

  • Checking a partner's phone or location, or demanding constant updates
  • Getting upset about time spent with friends or family
  • Using guilt ("after everything I've done for you")
  • Threatening to leave, or threatening to end the relationship first
  • Insisting on control over plans, money, or small daily decisions

Most of the time, this behavior is an attempt to prevent a feared abandonment. If you can predict where someone is and who they're with, the fear quiets for a while. Then it comes back, and the checking starts again. The relief never lasts, which is why the behavior tends to escalate rather than settle.

Understanding the cause is not the same as accepting the behavior. A partner doesn't have to tolerate being monitored, threatened, or cut off from friends. Clear boundaries ("I'll answer when I'm done with work, not every 10 minutes") protect both people, and they work best when they're calm, specific, and consistent. If controlling behavior includes threats of self-harm, take them seriously: see the crisis answer in the FAQ below.

Labels that end the conversation don't help. The fear underneath is what treatment works on.

How Petulant BPD Affects Relationships, Work, and Daily Life

In romantic relationships, the push-pull pattern is exhausting for both people. Closeness feels risky, distance feels like rejection, and arguments can start over very little. For example, a friend cancels plans because they're sick. A person with petulant BPD traits may hear "I don't want to see you," react with anger or a cold message, and then feel ashamed and afraid they've ruined the friendship.

Family members often describe walking on eggshells.

At work, feedback can land as a personal attack. A routine note from a manager may trigger defensiveness, resentment that lingers for days, or a sense of being singled out.

None of this means the person doesn't care. Often they care intensely, which is part of why every slight hurts so much.

Petulant BPD vs. Other Types of BPD

Millon's four types of BPD differ mainly in where the distress goes: inward, outward, or into action.

SubtypeHow distress showsTypical patternDiscouragedInwardDependent and avoidant, clings to a few people, turns anger on themselvesImpulsiveInto actionRisk-taking, thrill-seeking, acting before thinkingPetulantOutwardIrritability, resentment, stubbornness, push-pull relationshipsSelf-destructiveAgainst the selfSelf-sabotage and self-harm, bitterness turned inward

The impulsive, petulant, and self-destructive rows are general summaries of Millon's model, not findings from a single study.

The discouraged type is the one described as dependent and avoidant, with distress turned inward. It's the closest match to what people call quiet BPD. Petulant BPD is close to its opposite: the same fear of abandonment, expressed loudly.

What Causes Petulant BPD?

We found no research on causes specific to the petulant subtype. Research covers BPD as a whole, and it points to several factors working together.

Genetics and family history

BPD tends to run in families. Having a close relative with BPD raises the risk, and genes are thought to be one factor among several.

Brain differences in emotion regulation

Studies of people with BPD have found differences in brain areas that handle emotion and impulse control. These findings describe groups, not individuals, and it isn't clear whether these differences are a cause or a result of BPD.

Childhood trauma, neglect, or invalidation

Abuse, neglect, early loss, or growing up in a home where feelings were dismissed are common in the histories of people with BPD. Not everyone with BPD has this history.

Having risk factors doesn't mean someone will develop BPD. Plenty of people have several and never do.

How Petulant BPD Is Treated

Treatment for petulant BPD is treatment for BPD, tailored to the person. Psychotherapy comes first.

Dialectical behavior therapy (DBT)

DBT was developed specifically for people with BPD. It uses mindfulness and teaches skills to manage intense emotions, reduce self-destructive behavior, and improve relationships. For the petulant pattern, that can mean learning to ask for what you need without an explosion.

A 2017 meta-analysis in JAMA Psychiatry by Cristea et al. found DBT and psychodynamic approaches were the only therapy types more effective than control conditions, though effects were small and likely inflated by study bias. Therapy helps. Real change takes steady work over time.

Other therapies: mentalization-based therapy and CBT

  • Mentalization-based therapy (MBT) builds the ability to understand your own mental states and other people's, which helps when a neutral comment gets read as an attack.
  • Cognitive behavioral therapy (CBT) works on the link between thoughts, feelings, and actions, such as catching an all-or-nothing thought before it turns into an argument.

The role of medication

According to NIMH, the benefits of medication for BPD itself are unclear, and medication isn't usually the first treatment. A psychiatrist may prescribe it for specific symptoms or for co-occurring conditions such as depression, and weighs the benefits against side effects with the person.

Can Petulant BPD Get Better?

Yes. BPD is treatable, and many people find that symptoms ease with treatment over time. Progress usually isn't a straight line: good months, a setback, then a steadier stretch.

Alongside therapy, a few habits help:

  • Noticing triggers. Write down what happened right before an outburst. Patterns show up within a few weeks.
  • Practicing DBT skills between sessions, not only in them.
  • Keeping a mood journal, so you and your care team can see changes you might miss day to day.
  • Protecting sleep and moving your body. Poor sleep makes irritability worse for almost everyone.

These are supports, not substitutes for treatment.

How to Support Someone With Petulant BPD

If you love someone with petulant BPD traits, feeling tired, confused, and sometimes guilty is normal.

  • Validate the feeling, not the behavior. "I can see you're really hurt" doesn't mean "you're right to yell at me."
  • Set clear, consistent boundaries. Say what you will and won't do, then follow through every time.
  • Don't escalate. Step away from an argument that's spiraling and come back when you're both calmer.
  • Encourage professional care without making it an ultimatum in the heat of a fight.
  • Look after your own mental health. Your own therapist or a family support group is not a betrayal.

Our guide on how to help someone with mental health issues goes further into those conversations.

When to Seek Help and How We Treat BPD at Amae Health

Weekly therapy is enough for some people. Others need more structured care, especially when there is:

  • Self-harm or suicidal thoughts
  • BPD alongside depression, bipolar disorder, or substance use
  • Repeated crises, ER visits, or hospital stays
  • Relationships, work, or school falling apart despite outpatient therapy

Borderline Personality Disorder and co-occurring substance use disorder are among the conditions we specialize in at Amae Health. Our care is in person and led by psychiatrists, for adults 18 and older. Each patient has a multidisciplinary team under one roof: psychiatrists, therapists, primary care physicians, dietitians, health coaches, peer mentors, and clinical care coordinators. Depending on the level of support needed, care can include a Partial Hospitalization Program (PHP) or an Intensive Outpatient Program (IOP), alongside individual and group therapy. You can read more about our care model.

If petulant BPD traits are shaping your life or a loved one's, you can request an intake appointment and our team will talk through what kind of care fits.

Frequently Asked Questions

Is petulant BPD a real diagnosis?

No. The diagnosis is Borderline Personality Disorder; "petulant" is one of four descriptive subtypes from Theodore Millon's work, not a DSM-5-TR category. The label can still help people and families recognize a pattern of outward irritability, resentment, and push-pull relationships, and find information that fits what they're living with.

What is the difference between petulant BPD and quiet BPD?

Both share the fear of abandonment at the core of BPD. Petulant BPD turns distress outward, through irritability, resentment, and conflict. Quiet BPD, closest to Millon's discouraged type, turns it inward, so others may not notice.

How is petulant BPD treated?

The same way as BPD: psychotherapy first, including DBT, which was developed specifically for BPD, and options such as mentalization-based therapy. Medication may be used for specific symptoms or co-occurring conditions such as depression, decided with a psychiatrist.

Can petulant BPD get better?

Yes. BPD is treatable, and symptoms often ease with treatment over time. Recovery takes patience and usually isn't linear: setbacks happen, and they don't erase progress.

Is petulant BPD the same as narcissism?

No. Borderline Personality Disorder and Narcissistic Personality Disorder are separate diagnoses in the DSM-5-TR, even though both can involve anger and relationship conflict. A thorough evaluation by a mental health professional is the way to tell them apart, and some people meet criteria for both.

Why does someone with BPD try to control me?

Controlling behavior usually comes from fear of being left. That explains it, but it doesn't excuse harm. Calm, consistent boundaries and encouraging treatment help more than arguing about each incident.

What should I do if someone with BPD talks about suicide?

Take it seriously every time. Stay with them if it's safe, and call or text 988, the 988 Suicide & Crisis Lifeline. If there's immediate danger, call 911.

# min read

Does TMS Therapy Work? Evidence and Success Rates

By

Sonia Garcia

|

October 7, 2026

Does TMS therapy work? For many people whose depression has not responded to antidepressants, yes, and the research shows how many. The FDA cleared transcranial magnetic stimulation (TMS) for major depressive disorder in 2008 on the strength of sham-controlled trials, and more than a decade of real-world outcome data has followed. What the evidence does not support is an unqualified "TMS works." Outcomes vary from person to person, the numbers depend on how you define success, and the people who benefit most share a recognizable profile.

‍

Start with the definitions, because every statistic below depends on them.

What "Works" Means: Response vs. Remission

Depression research measures success on rating scales, and two thresholds matter.

‍

Response means a meaningful reduction in symptoms, usually defined as a 50% or greater drop in the score on a standard depression scale. Someone who responds feels noticeably better but may still have symptoms.

‍

Remission means the score falls below the scale's cutoff for depression. Symptoms are largely gone. Remission is the goal of treatment, and it is the harder bar to clear.

‍

Two more details shape every TMS success rate you will read. The scale matters: clinician-rated scales and patient questionnaires produce different numbers for the same group of people. And the population matters. TMS is studied almost entirely in people whose depression has already failed to respond to medication, so its rates should be compared with other treatments for that same group, not with a first antidepressant.

What the Clinical Evidence Shows

One of the key trials confirming TMS's effect was a randomized, sham-controlled study led by Mark George and published in Archives of General Psychiatry in 2010. It enrolled 199 adults with major depression who were not taking antidepressants, with 190 included in the analysis. During the blinded phase, 14.1% of people receiving active TMS reached remission, compared with 5.1% receiving sham stimulation. The odds of remission were 4.2 times higher with real treatment, and the number needed to treat was 12.

‍

Those figures look modest next to many TMS marketing pages. The blinded phase was short, the remission bar strict, and a sham-controlled design exists to prove an effect is real, not to show the best a treatment can do in practice. On that goal, it succeeded.

‍

Real-world outcomes come from a different kind of study. In 2012, Linda Carpenter and colleagues published a multisite observational study in Depression and Anxiety covering 307 outpatients treated at 42 clinical TMS practices across the United States. These patients had already tried an average of 2.5 antidepressants at adequate dose and duration without satisfactory improvement. By the end of treatment, 58% had responded and 37.1% were in remission on the clinician-rated scale. On the PHQ-9, a self-report questionnaire, 56.4% responded and 28.7% reached remission.

‍

Our own framing for patients is deliberately conservative: roughly half of people respond and roughly one in three reach remission, and those figures describe people who had not benefited from four or more antidepressants. So how effective is TMS for depression? For depression that has resisted medication, it helps about half of the people who complete a standard course, and it clears depression for about a third.

‍

One clarification about higher numbers you may have seen. Remission rates of 70% or 80% come from newer accelerated protocols, many sessions per day over about a week guided by brain imaging, in small early trials. The FDA has cleared a rapid-acting form of TMS, as the National Institute of Mental Health notes, but we do not offer accelerated protocols, and the figures in this article describe the standard daily course our clinics provide.

TMS Compared to Other Depression Treatments

Antidepressant medication remains first-line, and TMS is typically considered after it. Compared with switching to yet another medication, TMS acts on the brain directly rather than through the bloodstream, which is why it does not cause weight gain, sexual side effects, or sedation.

‍

Electroconvulsive therapy (ECT) produces larger and faster symptom reduction in head-to-head research, but it requires general anesthesia and can affect memory around the time of treatment, so it is reserved for severe or urgent situations. Esketamine (Spravato) and ketamine can act within days rather than weeks, with a different monitoring burden and a different side-effect profile. None of these is universally better. They suit different clinical pictures, and we compare each pairing in depth in dedicated articles.

Who Is Most Likely to Benefit

The evidence points to a consistent profile of the person who does well with TMS. It matches the eligibility criteria we use, which also track what insurers require for authorization:

‍

  • A confirmed diagnosis of major depressive disorder. TMS is cleared for MDD, not for every kind of low mood, and getting the diagnosis right comes first. If you are unsure how your diagnosis fits, our guide to major depressive disorder vs. persistent depressive disorder explains the distinction.
  • Multiple antidepressants from different classes that did not bring adequate improvement.
  • Psychotherapy that was tried and did not bring enough relief.
  • No medical contraindications. TMS uses a strong magnetic field, so we screen for a history of seizures or epilepsy, metal in the head outside the mouth, implanted devices such as pacemakers, and a history of stroke, neurosurgery, or brain injury. Pregnancy calls for individualized planning with your obstetric and psychiatric team. Ordinary dental fillings are not a problem.
  • The ability to commit to a daily session schedule for several weeks.

‍

Notice what is not on the list: how many years you have spent on medication. More than half of the Carpenter study's patients responded after multiple failed medication trials.

How Long It Takes to See Results

TMS is cumulative. A single session produces nothing you would notice; the benefit builds as repeated stimulation changes activity in the mood circuits being targeted. At our clinics, a full course of TMS means 20 to 30 weekday sessions over roughly four to six weeks.

‍

When improvement shows up varies. Some people notice sleep, energy, or concentration shifting in the second or third week, often before their mood lifts. Others feel little change until the final stretch of the course. Both patterns are normal, and neither predicts the final outcome well, which is why progress is judged with symptom rating scales rather than a mid-course impression. The most common mistake is writing TMS off after a handful of sessions.

What Happens If TMS Doesn't Work?

It is a fair question to ask before you start, and the answer is not "you are out of options."

‍

If symptom scores have not moved by the later part of the course, a psychiatrist reassesses rather than simply stopping. The treatment plan can be adjusted, including the stimulation parameters or the length of the course. Medication can be changed or added, since TMS and medication are often combined. Psychotherapy can be intensified. And other options for treatment-resistant depression remain on the table, including esketamine and, for severe or urgent depression, ECT.

‍

Partial response is its own category: a 30% drop in symptoms is not a treatment failure, and it often shapes what comes next. People who responded well to a first course can also be treated again if depression returns.

‍

What happens if TMS doesn't work is, in the end, what happens at every stage of treating difficult depression: the plan changes, and the person stays in care. If you are having thoughts of suicide at any point, call or text 988 to reach the Suicide and Crisis Lifeline.

What TMS Does Not Do

TMS is a specific tool, and its limits are as well defined as its strengths.

‍

It does not work for everyone. About half of people with medication-resistant depression respond, which means about half do not.

‍

It is not a first-line treatment. In practice, and in insurers' criteria, TMS comes after antidepressant trials, not instead of them.

‍

It is not a general-purpose brain treatment. The FDA clearances are specific: major depressive disorder since 2008 and obsessive-compulsive disorder since 2018, plus a small number of narrowly defined uses. Anxiety disorders and PTSD are being studied, but those uses are not cleared. At our clinics we currently provide TMS for major depressive disorder.

‍

It is not a cure. Remission is a realistic goal, but depression can return, and TMS belongs inside ongoing care rather than serving as a one-time fix.

What to Expect During a Course of Treatment

The practical side is simpler than most people expect.

‍

Treatment begins with a screening visit of 30 to 60 minutes to confirm the diagnosis, review your treatment history, and check for contraindications. Sessions then run Monday through Friday, 30 to 40 minutes each. You sit in a chair, awake, while a magnetic coil rests against your scalp and delivers pulses in short trains. It feels like tapping. With no anesthesia or sedation, you drive yourself home and go straight back to your day.

‍

Side effects are mostly local and mostly early: scalp discomfort at the coil site and headache, both of which typically clear within the first week. Because nothing enters your bloodstream, TMS does not cause the weight gain, sexual dysfunction, stomach upset, dry mouth, or sedation that antidepressants can. The one serious risk, seizure, is exceedingly rare, and the screening process exists to keep it that way.

Talking to a Psychiatrist About Whether TMS Is Right for You

Population statistics tell you what TMS does for people like you. They cannot tell you what it will do for you. That question gets answered in an evaluation, where a psychiatrist reviews your diagnosis, medication history, health, and goals, and tells you plainly whether TMS is a reasonable next step.

‍

At Amae, TMS is one part of an integrated care model in which psychiatry, therapy, primary care, and peer support come from the same team, so a course of TMS fits into your broader care rather than running alongside it. We provide it in Los Angeles, Los Altos, and San Mateo, all commercial insurance plans are accepted alongside cash pay, and prior authorization is handled by our intake team. To find out where you stand, schedule an evaluation with an Amae psychiatrist.

Frequently Asked Questions

What percentage of people does TMS work for?

In a major multisite real-world study, 58% of patients responded and 37% reached remission on clinician ratings after a standard course. Those patients had already tried an average of 2.5 antidepressants without adequate relief, so the numbers describe treatment-resistant depression, not depression in general. Our own conservative framing is that about half respond and about one in three reach remission.

How soon does TMS start working?

Gradually, over the course rather than after a single session. Some people notice changes in sleep, energy, or focus within the first two or three weeks, while others see improvement only near the end of the four-to-six-week course. Neither pattern reliably predicts the final result.

Does TMS work for everyone?

No. Like every treatment for depression, TMS produces a range of outcomes, and roughly half of people with medication-resistant depression do not respond. That is why a psychiatrist tracks symptoms during the course and adjusts the plan if progress stalls.

Is TMS FDA-approved or still experimental?

TMS is FDA-cleared, not experimental. Clearance for major depressive disorder came in 2008 and for obsessive-compulsive disorder in 2018, both on the basis of controlled clinical trials. Uses such as anxiety disorders and PTSD are still at the research stage and are not cleared.

What happens if TMS doesn't work for me?

A psychiatrist reassesses and lays out next steps. Those can include adjusting the treatment plan, combining TMS with medication changes or psychotherapy, or considering other treatment-resistant depression options such as esketamine or ECT. Not responding to TMS does not mean nothing else will work.

How long do the effects of TMS last?

It varies. Improvement often lasts well beyond the end of the course, some people need a maintenance plan or a repeat course, and the timing differs from person to person. Durability deserves its own discussion, and it is one to have with your psychiatrist as you approach the end of a course.

‍

Citations

  1. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry. 2010. https://pubmed.ncbi.nlm.nih.gov/20439832/
  2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/
  3. Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depression Research and Treatment. 2014. https://pubmed.ncbi.nlm.nih.gov/25143831/
  4. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
  5. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍